Dickkopf-3 in Human Malignant Tumours: A Clinical Viewpoint
Citations

WEB OF SCIENCE

14
Citations

SCOPUS

14

초록

Dickkopf-3 (DKK3), also known as REIC, is a secreted glycoprotein. DKK3 is aberrantly expressed in various types of human malignant tumours. Promoter methylation status, intracellular protein expression, and protein expression in tumour vessels are significantly correlated with clinical prognostic factors, including survival. In malignant cells, DKK3 is involved in the induction of apoptosis, inhibition of invasion, and remodelling of tumour vasculature. These activities are carried out via the regulation of the beta-catenin signalling and c-Jun N-terminal kinase-dependent cellular pathway, both of which are critical for carcinogenesis. This review explores the potential value of DKK3 as a clinical biomarker and a therapeutic candidate in human malignancies.

키워드

Dickkopf-3clinical biomarkermalignant tumourtherapeuticsreviewREIC/DKK-3 GENE-THERAPYANTAGONIST FAMILY GENESWNT SIGNALING PATHWAYDOWN-REGULATIONREDUCED EXPRESSIONBETA-CATENINPROMOTER METHYLATIONCOLORECTAL-CANCERDKK-3 EXPRESSIONREIC GENE
제목
Dickkopf-3 in Human Malignant Tumours: A Clinical Viewpoint
저자
Lee, Eun-JuNguyen, Que Thanh Thanh Lee, Mooyul
DOI
10.21873/anticanres.14617
발행일
2020-11
유형
Review
저널명
Anticancer Research
40
11
페이지
5969 ~ 5979